Livanova Plc (LIVN) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Livanova Plc  (NASDAQ: LIVN)


Livanova Plc's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Livanova Plc's ROA in the third quarter of 2026?
Livanova Plc achieved a return on average assets (ROA) of 7.46 % in its third quarter of 2026, this is above LIVN's average return on assets of -4.24%.
Livanova Plcs assets during the 12 months ending in the third quarter of 2026 are valued at $2 billion

Despite the company's net income deteriorating, Livanova Plc was able to improve its ROA compared to the second quarter of 2026.

However, within the Healthcare sector 123 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 1329, from total ROA ranking in the second quarter of 2026 at 3744.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Total Assets Change 6.08 % 5.35 % -0.93 % 11.74 % 8.24 %
Y / Y Net Income Change 28.04 % 299.72 % - -44.7 % -18.72 %
Net Income (TTM) in million 196 189 107 -242 -217
Return On Assets (TTM) 7.46 % 7.28 % 4.19 % -9.46 % -8.72 %
LIVN's Total Ranking # 1329 # 3744 # 3244 # 3231 # 3290
Total Assets (TTM) in million 2,713 2,641 2,535 2,626 2,558
Seq. Total Assets Change 2.74 % 4.18 % -3.48 % 2.69 % 2.03 %
Seq. Net Income Change -68.41 % 386.99 % -27.87 % 15.39 % -1.39 %

LIVN's 5 Years Annual ROA >> Back to LIVN Management Effectiveness >> Compare LIVN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 38
Sector # 124
Overall # 857

Return On Assets Statistics
High Average Low
7.31 %
-4.24 %
-17.56 %
(Jun 30 2026)   (Sep 30 2021)





Financial Statements
Livanova Plc's Assets $ 2,713 million LIVN's Balance sheet
Livanova Plc's Income $ 34 million Quarterly LIVN's Income Statement
LIVN's Income by Division See LIVN's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 11.74 % 3.87 % 0.13 % 4.66 % -32.35 %
Total Assets in million 2,626 2,350 2,263 2,260 2,159
Y / Y Net Income Change - 260.39 % - - -
Net Income in million -242 63 18 -86 -136
Annual Return On Assets -9.23 % 2.69 % 0.78 % -3.82 % -6.29 %

LIVN's 5 Years Annual ROA >> Back to LIVN Management Effectiveness >> Compare LIVN ROA to its Competitors



More Return On Assets Ratios
LIVN's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
LIVN's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for LIVN's Competitors
Subscribers only: Roa for Livanova Plc's Suppliers
Subscribers only: Return On Assets for LIVN's Customers

You may also want to know
LIVN's Roi LIVN's Inventory Turnover Ratio LIVN's Growth Rates LIVN's Dividend Comparisons
LIVN's Profitability Ratios LIVN's Asset Turnover Ratio LIVN's Dividend Growth
LIVN's Roe LIVN's Valuation Ratios LIVN's Financial Strength Ratios LIVN's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA
Resmed Inc   18.67 %
Alector Inc   18.37 %
Corcept Therapeutics Inc  18.09 %
Chemed Corporation  17.73 %
Halozyme Therapeutics Inc   17.26 %
Pro dex Inc   16.75 %
Denali Therapeutics Inc   16.42 %
Krystal Biotech Inc   15.48 %
West Pharmaceutical Services Inc   15.47 %
Dexcom Inc   15.47 %
Intuitive Surgical Inc   14.71 %
Vertex Pharmaceuticals Inc  14.16 %
Neurocrine Biosciences Inc   13.69 %
Illumina Inc   13.43 %
Healthcare Services Group Inc   12.79 %
Kiniksa Pharmaceuticals International Plc  12.64 %
Tenet Healthcare Corp  12.39 %
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %
Lantheus Holdings Inc   11.43 %
Msa Safety Inc  11.01 %
Encompass Health Corporation  10.99 %
Inspire Medical Systems inc   10.89 %
Transmedics Group Inc   10.67 %
Bristol myers Squibb Company  10.47 %
Lemaitre Vascular Inc   10.28 %
Bio rad Laboratories Inc   9.88 %
3m Company  9.60 %
Bioventus Inc   9.47 %

Date modified: 2026-11-07T13:22:31+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.